Table 1.

Results of correlation analysis between myeloma incidence and mortality rates and important variables of economic factors, access and quality of health care, and patient empowerment

Parameters	Incidence	1‐MIR	GDP	HAQ Index	HC expenditures	Patient empowerment	Access to cancer drugs
Incidence
ρ		0.83	0.58	0.70	0.68	0.81	0.69
p value		.0001	.0001	.0001	.0001	.0001	.0024
1‐MIR
ρ	0.83		0.56	0.73	0.59	0.71	0.67
p value	.0001		.0001	.0001	.0001	.0001	.0032
GDP
ρ	0.58	0.56		0.83	0.87	0.82	0.84
p value	.0001	.0001		.0001	.0001	.0001	.0001
HAQ Index
ρ	0.70	0.73	0.83		0.85	0.86	0.64
p value	.0001	.0001	.0001		.0001	.0001	0.0057
HC Expenditures
ρ	0.68	0.59	0.87	0.85		0.89	0.85
p value	.0001	.0001	.0001	.0001		.0001	.0001
Patient empowerment
ρ	0.81	0.71	0.82	0.86	0.89		0.84
p value	.0001	.0001	.0001	.0001	.0001		.0001
Access to cancer drugs
ρ	0.69	0.67	0.84	0.64	0.85	0.84
p value	.0024	.0032	.0001	.0057	.0001	.0001

Abbreviations: GDP, gross domestic product; HAQ, health care access and quality; HC, health care; MIR, mortality‐to‐incidence ratio.